Literature DB >> 15728748

Major and subthreshold depression among older adults seeking vision rehabilitation services.

Amy Horowitz1, Joann P Reinhardt, Gary J Kennedy.   

Abstract

OBJECTIVE: Authors examined the potential risk factors of major and subthreshold depression among elderly persons seeking rehabilitation for age-related vision impairment.
METHODS: Participants (N=584), age 65 and older, with a recent vision loss, were new applicants for rehabilitation services. Subthreshold depression was defined as a depressive syndrome not meeting criteria for a current major depression (i.e., minor depression, major depression in partial remission, dysthymia) or significant depressive symptomatology.
RESULTS: Seven percent of respondents had a current major depression, and 26.9% met the criteria for a subthreshold depression. Poorer self-rated health, lower perceived adequacy of social support, decreased feelings of self-efficacy, and a past history of depression increased the odds of both a subthreshold and major depression, versus no depression, but greater functional disability and experiencing a negative life event were significant only for a subthreshold depression. Only a history of past depression was significant in increasing the odds of having a major versus a subthreshold depression.
CONCLUSION: Results highlight similarities in characteristics of, and risk factors for, subthreshold and major depression. Future research is needed to better understand both the trajectory and treatment of subthreshold depression, relative to major depressive disorders.

Entities:  

Mesh:

Year:  2005        PMID: 15728748     DOI: 10.1176/appi.ajgp.13.3.180

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  37 in total

1.  Why visually impaired older adults often do not receive mental health services: the patient's perspective.

Authors:  Hilde P A van der Aa; Mirke Hoeben; Linda Rainey; Ger H M B van Rens; Hilde L Vreeken; Ruth M A van Nispen
Journal:  Qual Life Res       Date:  2014-11-15       Impact factor: 4.147

Review 2.  A tune in "a minor" can "b major": a review of epidemiology, illness course, and public health implications of subthreshold depression in older adults.

Authors:  Thomas W Meeks; Ipsit V Vahia; Helen Lavretsky; Ganesh Kulkarni; Dilip V Jeste
Journal:  J Affect Disord       Date:  2011-03       Impact factor: 4.839

3.  [Quality of life by limited vision in old age: the example of age-related macula degeneration].

Authors:  H-W Wahl; V Heyl; N Langer
Journal:  Ophthalmologe       Date:  2008-08       Impact factor: 1.059

Review 4.  Use of antidepressants in older patients with co-morbid medical conditions: guidance from studies of depression in somatic illness.

Authors:  Gary J Kennedy; Paula Marcus
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Psychological and cognitive determinants of vision function in age-related macular degeneration.

Authors:  Barry W Rovner; Robin J Casten; Robert W Massof; Benjamin E Leiby; William S Tasman
Journal:  Arch Ophthalmol       Date:  2011-07

6.  Baseline traits of low vision patients served by private outpatient clinical centers in the United States.

Authors:  Judith E Goldstein; Robert W Massof; James T Deremeik; Sonya Braudway; Mary Lou Jackson; K Bradley Kehler; Susan A Primo; Janet S Sunness
Journal:  Arch Ophthalmol       Date:  2012-08

7.  Depression in Age-Related Macular Degeneration.

Authors:  Robin Casten; Barry Rovner
Journal:  J Vis Impair Blind       Date:  2008

8.  Longitudinal incidence of adverse outcomes of age-related macular degeneration.

Authors:  Ashley Wysong; Paul P Lee; Frank A Sloan
Journal:  Arch Ophthalmol       Date:  2009-03

9.  The effects of developing a dual sensory loss on depression in older adults: a longitudinal study.

Authors:  Michele Capella McDonnall
Journal:  J Aging Health       Date:  2009-12

10.  Low vision depression prevention trial in age-related macular degeneration: a randomized clinical trial.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Robert W Massof; Benjamin E Leiby; Allen C Ho; William S Tasman
Journal:  Ophthalmology       Date:  2014-07-09       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.